About

Aims and scope

Journal of Pharmaceutical Policy and Practice (formerly known as Southern Med Review) provides a platform for researchers to disseminate empirical research findings, with the aim that people everywhere have access to the medicines they need and use them rationally.

The Journal encompasses all aspects of pharmacy including clinical, social, administrative or economic, and provides a platform to researchers, academics and practitioners from around the world to share new evidence, concerns and perspectives.

Open access

All articles published by Journal of Pharmaceutical Policy and Practice are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

As authors of articles published in Journal of Pharmaceutical Policy and Practice you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.

For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Journal of Pharmaceutical Policy and Practice therefore levies an article-processing charge of £1430.00/$2240.00/€1820.00 for each article accepted for publication.

If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

BioMed Central provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service. 

Indexing services

All articles published in Journal of Pharmaceutical Policy and Practice are included in:

  • DOAJ
  • National Library of New Zealand
  • PubMed Central
  • Scopus
  • ​WHO's Essential Medicines Documentation Database

The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.

We are working closely with relevant indexing services including Web of Science (Clarivate Analytics) to ensure that articles published in Journal of Pharmaceutical Policy and Practice will be available in their databases when appropriate.

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Journal of Pharmaceutical Policy and Practice operates a double-blind peer-review system, where the reviewers do not know the names or affiliations of the authors and the reviewer reports provided to the authors are anonymous.

Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.

Benefits of double-blind peer review
Double-blind peer review allows reviewers to judge the manuscript based on content alone, and are not biased by knowledge of who the authors are.

Editorial policies

All manuscripts submitted to Journal of Pharmaceutical Policy and Practice should adhere to BioMed Central's editorial policies.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Citing articles in Journal of Pharmaceutical Policy and Practice

Articles in Journal of Pharmaceutical Policy and Practice  should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. J Pharm Policy and Pract [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. J Pharm Policy and Pract 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Appeals and complaints

If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.

Why publish your article in Journal of Pharmaceutical Policy and Practice

High visibility

Journal of Pharmaceutical Policy and Practice's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. 

Speed of publication

Journal of Pharmaceutical Policy and Practice offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.

Flexibility

Online publication in Journal of Pharmaceutical Policy and Practice gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Journal of Pharmaceutical Policy and Practice are included in article alerts and regular email updates. Some may be highlighted on Journal of Pharmaceutical Policy and Practice’s pages and on the BioMed Central homepage.

In addition, articles published in Journal of Pharmaceutical Policy and Practice may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Journal of Pharmaceutical Policy and Practice. A list of articles recently press-released by journals published by BioMed Central is available here.

Copyright

As an author of an article published in Journal of Pharmaceutical Policy and Practice you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.